<?xml version="1.0" encoding="UTF-8"?>
<p>Favipiravir (FPV) is a guanine analog, also selectively inhibiting RdRp (like remdesivir) that has been approved for the treatment of influenza.
 <sup>
  <xref rid="R22" ref-type="bibr">22</xref>
 </sup> The clinical evaluation for its efficacy and safety in the therapy of COVID-19 is ongoing (ChiCTR2000029600).
</p>
